Industries

• Reset all ×
• Life Sciences ×
• North America ×
• Industry Statistics ×
• 2022 ×

Showing all 2 results

Sort by popularity Sort by average rating Sort by latest Sort by price: low to high Sort by price: high to low

• 

  Revenue Cycle Management (RCM) Market in United States 2022

  Revenue Cycle Management (RCM) refers to the process of identifying, collecting and managing the practice’s revenue from payers based on the services provided. A successful RCM process is essential for a healthcare practice to maintain financial viability and continue to provide quality care for its patients. A study by StrategyHelix indicates that the revenue cycle management market in United States is expected to increase by US$ 33,743 million from 2022 to 2028, garnering a CAGR of 15.9% during the forecast period. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the revenue cycle management market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 550
• 

  Liquid Biopsy Market in United States 2022

  A liquid biopsy is a simple and non-invasive alternative to surgical biopsies which enables doctors to discover a range of information about a tumour through a simple blood sample. Traces of the cancer’s DNA in the blood can give clues about which treatments are most likely to work for that patient. According to StrategyHelix, the liquid biopsy market in United States is expected to increase by US$ 3.80 billion during 2022-2028, expanding at a CAGR of 11.7% during the forecast period. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the liquid biopsy market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 750